Interestingly, microglia from APP/PS1 mice show an increase in the murine FPR1 and FPR2 [46], and treatment of APP/PS1 mice with a competitive FPR inhibitor ameliorated cognitive impairment, reduced plaque load, and lessened microglial reactivity [384]. This evidence concerns the gene PSEN1 and Cognitive impairment.